RocketTickers

Supernus Announces Positive Results from Phase III Study For SPN

Long
NASDAQ:SUPN   Supernus Pharmaceuticals, Inc
SUPN: Supernus Pharmaceuticals , Inc.
2018-12-20 07:00:00
Supernus Announces Positive Results from Phase III Study For SPN-812 in Adolescents with ADHD